← Leaderboards
Rachel Saunders-Pullman
Beth Israel Medical Ctr (New York)
$5,777,194
Attributed
$9,805,631
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2005–23$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$10,817,412 · 5
By mechanism
U01$8,056,874 · 2
P20$1,011,781 · 1
K02$879,347 · 1
K23$869,410 · 1
Top collaborators
- Laurie J. Ozelius6 shared
- Dimitri Krainc4 shared
- Zhenyu Yue2 shared
Others in their field
Top investigators on “Parkinson Disease”
- Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$92,426,001
- David M Anderson · University Of Washington$40,483,703
- Daniel M Corcos · Northwestern University$37,632,589
- Joel Synes Perlmutter · Washington University$37,192,743
- Jerrold L Vitek · University Of Minnesota$35,135,315
- Joseph B Martin · Harvard University (Medical School)$26,652,023
Research focus
Parkinson DiseaseBaseCohortGeneticMutationHeterogeneityEtiologyProgramsIsraelEvaluationSamplingDisease ProgressionBiological MarkersFollower Of Religion JewishMutation CarrierFunctional DisorderAshkenazimLrrk2 GenePreventSubgroupMotorPathway InteractionsBrainMovement Disorders
Grant awards (22)
Dissecting Oligogenic Biomarkers in Ashkenazi Jews with Parkinson Disease$1,529,016
U01 · FY2023 · NS · contact PI
Dissecting Oligogenic Biomarkers in Ashkenazi Jews with Parkinson Disease$1,222,953
U01 · FY2022 · NS · contact PI
Molecular and Cellular Basis of the Gut-Brain Axis in Parkinsons Disease$504,974
P20 · FY2022 · NS
Dissecting Oligogenic Biomarkers in Ashkenazi Jews with Parkinson Disease$1,123,564
U01 · FY2021 · NS · contact PI
Molecular and Cellular Basis of the Gut-Brain Axis in Parkinsons Disease$506,807
P20 · FY2021 · NS
Dissecting Oligogenic Biomarkers in Ashkenazi Jews with Parkinson Disease$352,792
U01 · FY2021 · NS · contact PI
Dissecting Oligogenic Biomarkers in Ashkenazi Jews with Parkinson Disease$1,241,583
U01 · FY2020 · NS · contact PI
Dissecting Oligogenic Biomarkers in Ashkenazi Jews with Parkinson Disease$1,141,563
U01 · FY2019 · NS · contact PI
Evaluation of glucocerebrosidase pathway biomarkers in Parkinson Disease$374,425
U01 · FY2017 · NS · contact PI
Evaluation of glucocerebrosidase pathway biomarkers in Parkinson Disease$418,873
U01 · FY2016 · NS · contact PI
Evaluation of glucocerebrosidase pathway biomarkers in Parkinson Disease$558,458
U01 · FY2015 · NS · contact PI
Phenotypic Spectrum of LRRK2 Mutations$149,597
K02 · FY2015 · NS · contact PI
Evaluation of glucocerebrosidase pathway biomarkers in Parkinson Disease$93,647
U01 · FY2015 · NS · contact PI
Phenotypic Spectrum of LRRK2 Mutations$149,597
K02 · FY2014 · NS · contact PI
Phenotypic Spectrum of LRRK2 Mutations$203,597
K02 · FY2013 · NS · contact PI
Phenotypic Spectrum of LRRK2 Mutations$188,795
K02 · FY2012 · NS · contact PI
Phenotypic Spectrum of LRRK2 Mutations$187,761
K02 · FY2011 · NS · contact PI
Gender and Hormonal Differences in Parkinson's Disease$173,882
K23 · FY2008 · NS · contact PI
Gender and Hormonal Differences in Parkinson's Disease$173,882
K23 · FY2007 · NS · contact PI
Gender and Hormonal Differences in Parkinson's Disease$173,882
K23 · FY2006 · NS · contact PI
Gender and Hormonal Differences in Parkinson's Disease$173,882
K23 · FY2005 · NS
Gender and Hormonal Differences in Parkinson's Disease$173,882
K23 · FY2004 · NS